Kraft-Heinz Continues to Fall


In May 2017 we looked at the proposed merger between Kraft-Heinz and Unilever, where we discussed the differing approaches to business taken by the two entities. Then, in May 2019, we looked at Kraft-Heinz again as it was under investigation by the SEC because of its accounting situation. More recently however, the company has continued to struggle and now it is the turn of the credit rating agencies to weigh-in and affect the situation for the struggling firm.

It was reported last week that, on the basis of Kraft-Heinz’s decision to maintain its dividend payouts to its shareholders despite an ever-growing debt burden, both S&P and Fitch would be downgrading the company to junk status i.e. non-investment grade. S&P cited the ‘unwillingness’ to change course on the dividend decision as a key factor in the downgrade decision, although the company has countered by declaring that ‘we believe it’s important to shareholders to maintain our dividend during this time of transformation’. Nevertheless, this ‘unwillingness’ as S&P see it, when combined with what S&P have declared has been ‘significant mismanagement’ over recent years, all adds up to a downgrade that could be massively impactful for a firm that needs to borrow, but who will now be barred from the investment-grade indices. For Fitch, it warned that the company may need to raise $9 billion from disposals to reduce its levels of leverage. Interestingly, Moody’s chose not to downgrade the company, instead placing it on a negative watch for a downgrade – I say interesting because Kraft-Heinz’s largest shareholder is also Moody’s’ largest shareholder; Warren Buffett’s Berkshire Hathaway.

If we look closer at Kraft-Heinz we can see that this turn of events should hardly be surprising and, in hindsight, why Unilever were so reluctant to get involved. Kraft-Heinz and its management has come in for plenty of criticism in recent years, and one of the main reasons is the approach taken by one of its constituent components – 3G Capital. 3G Capital, a Brazilian-based outfit, are renowned for creating profits via extensive and relentless cost-cutting strategies; the Kraft-Heinz deal was said to be based upon the fact that, at Heinz, there was very little else to cut and there was a need to bring in another high-cost business in order to keep the strategy going. This cost-cutting is continuing with Kraft-Heinz, but it is also being done with a challenging market place. Its products are increasingly falling out of favour with consumers, who are turning to fresher products than that offered by Kraft-Heinz. In response, Kraft-Heinz are embarking upon a strategy of reducing their selection of new products and also revitalising their current product base, in line with increased investment in its marketing campaigns for its increasingly outdated products. Yet, there is very little to suggest that the company will be on the mend anytime soon. The downgrades will have an effect and, if Moody’s decides to downgrade too, the situation will only get worse. Adding to the fact that it appears the company’s traditional position in the marketplace has been taken for granted whilst the market has moved on significantly, one can only imagine that it will take something special from the company’s management to arrest this slide – and if S&P’s declaration of mismanagement is true, then that seems to be a long-shot.

Keywords – Kraft-Heinz, junk, downgrade, credit ratings, @finregmatters

Comments

Post a Comment

Popular posts from this blog

Lloyds Bank and the PPI Scandal: The Premature ‘Out of the Woods’ Rhetoric

Image
Today’s very short post focuses upon the news that the Financial Conduct Authority (FCA) has recently extended the deadline to claim compensation for mis-sold ‘Payment Protection Insurance’ (PPI). Whilst a lot of financial institutions will have to prepare to offset the extended deadline, it is Lloyds that has grabbed the business headlines by apportioning an extra £350 million to offset any further claims that may be made of it – however, this comes only a week or two after the Bank posted its best performance figures in over a decade, as was previously discussed in Financial Regulation Matters . This post will therefore argue that the rhetoric being advanced recently regarding Lloyds – rhetoric like Lloyds represents ‘ a modern day success story ’ is wide of the mark and creates a false sense of security that we simply cannot afford to believe in. The ‘ robust recovery ’ was heralded far and wide upon the publication of Lloyds Bank’s financial performance for the previous fi
Read more

The Analytical Credit Rating Agency: A New Entrant That Will Further Enhance Russia’s Isolation

Image
This short post is based upon a forthcoming article by this author that examines the viability of the latest entrant into the credit rating arena, the Analytical Credit Rating Agency (ACRA). The article, which is due to be published in the European Company Law Journal (and is available here in a pre-published version), looks at the chances of the ACRA succeeding when viewed within the parameters of perception , an aspect that underpins the credit rating sector. For this post, the focus will be upon introducing the ACRA, and then on examining the effect it may have upon the wider political issues affecting the Russian Federation. The Analytical Credit Rating Agency was established in November 2015 and comprises of 27 major Russian companies and financial institutions that serve as its shareholders. The agency, which became the first rating agency to receive accreditation from the Russian Central Bank under the new N 222-FZ Law which was designed to protect investors, has a re
Read more

The Case of Purdue Pharma, the Sackler Family, and the Opioid Crisis

Image
In the first of two short posts today, we will look at the case of the billionaire Sackler Family and their remarkable effect upon American society. The family, who own Purdue Pharma amongst a list of other ventures, have this week seen a massive legal action taken against them by the State of New York who argue that the company is ‘ responsible for the opioid epidemic ’ sweeping through the United States. The attorney-general for New York has called the lawsuit the ‘ nation’s most extensive ’ with respect to the pharmaceutical industry and comes right on the heels of a $270 million suit that was settled in the State of Oklahoma on exactly the same grounds. Whilst the company and the billionaire family who own it did not admit guilt (settling parties rarely do, hence why they settle outside of court) it has potentially opened the trapdoors for litigation. It comes as no surprise then that the company is reportedly considering bankruptcy proceedings in the face of such an onsl
Read more